Xalkori® (crizotinib)
for Lung Cancer

Xalkori (crizotinib) is an oral kinase inhibitor used to treat adults with metastatic non-small cell lung cancer (NSCLC) caused by ALK or ROS1 gene defects. It’s also used in children 1+ and young adults with ALK-positive anaplastic large cell lymphoma (ALCL) or inflammatory myofibroblastic tumors (IMT) that can’t be removed or have returned. Xalkori blocks abnormal receptor tyrosine kinases to slow cancer cell growth and survival.

Heart